A detailed history of Fmr LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Fmr LLC holds 701,739 shares of BNTX stock, worth $81.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
701,739
Previous 834,390 15.9%
Holding current value
$81.1 Million
Previous $77 Million 26.74%
% of portfolio
0.0%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$80.36 - $102.87 $10.7 Million - $13.6 Million
-132,651 Reduced 15.9%
701,739 $56.4 Million
Q1 2024

May 13, 2024

BUY
$88.96 - $112.35 $62 Million - $78.4 Million
697,426 Added 509.2%
834,390 $77 Million
Q4 2023

Feb 13, 2024

SELL
$90.91 - $112.75 $9.17 Million - $11.4 Million
-100,880 Reduced 42.41%
136,964 $14.5 Million
Q3 2023

Nov 13, 2023

BUY
$98.5 - $125.08 $1.03 Million - $1.3 Million
10,422 Added 4.58%
237,844 $25.8 Million
Q2 2023

Aug 11, 2023

SELL
$102.58 - $129.66 $74,062 - $93,614
-722 Reduced 0.32%
227,422 $24.5 Million
Q1 2023

May 11, 2023

BUY
$122.57 - $153.67 $5.59 Million - $7.01 Million
45,592 Added 24.97%
228,144 $28.4 Million
Q4 2022

Feb 13, 2023

SELL
$118.43 - $186.05 $9.69 Million - $15.2 Million
-81,803 Reduced 30.94%
182,552 $27.4 Million
Q3 2022

Nov 10, 2022

SELL
$127.65 - $183.11 $20.3 Million - $29.2 Million
-159,412 Reduced 37.62%
264,355 $35.7 Million
Q2 2022

Aug 12, 2022

SELL
$123.25 - $186.24 $102 Million - $154 Million
-828,309 Reduced 66.15%
423,767 $63.2 Million
Q1 2022

May 13, 2022

BUY
$126.25 - $231.85 $117 Million - $214 Million
923,552 Added 281.12%
1,252,076 $214 Million
Q4 2021

Feb 14, 2022

SELL
$216.64 - $362.52 $313 Million - $524 Million
-1,445,165 Reduced 81.48%
328,524 $84.7 Million
Q3 2021

Nov 15, 2021

SELL
$205.93 - $447.23 $46 Million - $99.9 Million
-223,324 Reduced 11.18%
1,773,689 $484 Million
Q2 2021

Aug 13, 2021

BUY
$113.32 - $241.49 $226 Million - $482 Million
1,997,013 New
1,997,013 $447 Million

Others Institutions Holding BNTX

About BioNTech SE


  • Ticker BNTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 242,684,992
  • Market Cap $28.1B
  • Description
  • BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...
More about BNTX
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.